The latest update is out from Immunocore Holdings (IMCR).
The Company is poised to discuss its fourth-quarter and full-year earnings for 2023 on February 28, 2024, using a detailed corporate presentation. Investors should note that the presentation’s content is informational and won’t be considered part of the official legal filings for regulatory purposes. This approach ensures transparency while clarifying the presentation’s role in the Company’s official documentation.
Find detailed analytics on IMCR stock on TipRanks’ Stock Analysis page.
